Advocacy intelligence hub — real-time data for patient organizations
Andrew Dauber — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Epileptic encephalopathy with global cerebral demyelination news →
View all Epileptic encephalopathy with global cerebral demyelination specialists →